. Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment. Sci Transl Med. 2024 Jun 26;16(753):eadn3504. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. CSF Proteomics Hints at How ApoE4 Promotes AD, and How a Drug Hinders It

Mutations

  1. APOE C130R (ApoE4)